UroGen Pharma Ltd.
(URGN - NASDAQ)
23,77 USD
📋 Profilo Aziendale

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases.

|